Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1504
https://www.valueinhealthjournal.com/article/S1098-3015(15)03580-9/fulltext
Title : Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03580-9&doi=10.1016/j.jval.2015.09.1504
First page : A588
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 1407
Categories :
Tags :
Regions :
ViH Article Tags :